中国基层医药
中國基層醫藥
중국기층의약
Chinese Journal of Primary Medicine and Pharmacy
2015年
21期
3270-3272
,共3页
功能性胃肠病%氟哌噻吨美利曲辛%腹痛%临床疗效
功能性胃腸病%氟哌噻噸美利麯辛%腹痛%臨床療效
공능성위장병%불고새둔미리곡신%복통%림상료효
Functional gastrointestinal disorders%Fluoride faction shouted tons melitracen%Abdominal pain%Clinical efficacy
目的:研究并分析氟哌噻吨美利曲辛片(黛力新)应用于腹痛症状明显的功能性胃肠病(FGIDs)的治疗效果。方法82例伴有腹痛的 FGIDs 患者,按照随机原则分成 A 组(n =40)和 B 组(n =42), A 组实施常规治疗模式,B 组在 A 组的基础上加用黛力新进行治疗,对两组治疗总有效率以及不良反应发生情况进行对比分析。结果B 组治疗总有效率(90.24%)明显高于 A 组(65.85%),差异有统计学意义(χ2=4.538,P <0.05);两组在治疗过程中无严重不良反应出现,对两组不良反应发生率进行对比,差异无统计学意义(P >0.05)。结论黛力新应用于腹痛症状明显的 FGIDs 治疗能够取得令人满意的治疗效果,该药能够明显缓解腹痛症状,且安全性高,不会引起严重不良反应。
目的:研究併分析氟哌噻噸美利麯辛片(黛力新)應用于腹痛癥狀明顯的功能性胃腸病(FGIDs)的治療效果。方法82例伴有腹痛的 FGIDs 患者,按照隨機原則分成 A 組(n =40)和 B 組(n =42), A 組實施常規治療模式,B 組在 A 組的基礎上加用黛力新進行治療,對兩組治療總有效率以及不良反應髮生情況進行對比分析。結果B 組治療總有效率(90.24%)明顯高于 A 組(65.85%),差異有統計學意義(χ2=4.538,P <0.05);兩組在治療過程中無嚴重不良反應齣現,對兩組不良反應髮生率進行對比,差異無統計學意義(P >0.05)。結論黛力新應用于腹痛癥狀明顯的 FGIDs 治療能夠取得令人滿意的治療效果,該藥能夠明顯緩解腹痛癥狀,且安全性高,不會引起嚴重不良反應。
목적:연구병분석불고새둔미리곡신편(대력신)응용우복통증상명현적공능성위장병(FGIDs)적치료효과。방법82례반유복통적 FGIDs 환자,안조수궤원칙분성 A 조(n =40)화 B 조(n =42), A 조실시상규치료모식,B 조재 A 조적기출상가용대력신진행치료,대량조치료총유효솔이급불량반응발생정황진행대비분석。결과B 조치료총유효솔(90.24%)명현고우 A 조(65.85%),차이유통계학의의(χ2=4.538,P <0.05);량조재치료과정중무엄중불량반응출현,대량조불량반응발생솔진행대비,차이무통계학의의(P >0.05)。결론대력신응용우복통증상명현적 FGIDs 치료능구취득령인만의적치료효과,해약능구명현완해복통증상,차안전성고,불회인기엄중불량반응。
Objective To study and analyze the effect of fluoride faction shouted tons melitracen sheet (Deanxit)on abdominal pain symptoms of functional gastrointestinal disorders (FGIDs).Methods 82 patients with abdominal pain FGIDs were randomly divided into A group(n =40)and B group(n =42).A group was given conven-tional treatment,group B was given deanxit treatment on the basis of A group.The treatment efficacy and the total inci-dence of adverse reactions were analyzed.Results The total effective rate of group B (90.24%)was significantly higher than that in group A (65.85%),the difference was statistically significant (χ2 =4.538,P <0.05).There were no serious adverse reactions observed during treatment in the two groups,the incidence rate of adverse reactions between the two groups had no statistically significant difference (P >0.05).Conclusion Deanxit in the treatment of FGIDs can achieve satisfactory therapeutic effect,the drug can significantly alleviate the symptoms,andit is safe and without serious side effects.